0001193125-26-205087
SEC filingNovonix Limited director Michael O’Kronley acquired 5,862,567 performance rights on May 5, 2026, following shareholder approval at the April 15, 2026 AGM, increasing his total holdings to 9,586,538 performance rights valued at $1,524,267.
This Appendix 3Y filing discloses a significant increase in director Michael O’Kronley’s holdings of performance rights, more than doubling his position from approximately 3.7 million to 9.6 million units. The issuance, approved by shareholders at the April 15, 2026 AGM, aligns executive incentives with long-term shareholder value creation. Valued at over $1.5 million based on the prior day's closing price, it signals confidence in Novonix’s future prospects. No changes in contractual interests were reported, and the transaction occurred outside any closed period, maintaining compliance with ASX listing rules.